Armistice Capital, LLC 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-15 12:24 pm Sale | 2025-06-30 | 13G | BRIACELL THERAPEUTICS CORP BCTX | Armistice Capital, LLC | 33,600 8.310% | -400 (-1.18%) | Filing |